BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29463886)

  • 1. A set of regulatory genes co-expressed in embryonic human brain is implicated in disrupted speech development.
    Eising E; Carrion-Castillo A; Vino A; Strand EA; Jakielski KJ; Scerri TS; Hildebrand MS; Webster R; Ma A; Mazoyer B; Francks C; Bahlo M; Scheffer IE; Morgan AT; Shriberg LD; Fisher SE
    Mol Psychiatry; 2019 Jul; 24(7):1065-1078. PubMed ID: 29463886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe childhood speech disorder: Gene discovery highlights transcriptional dysregulation.
    Hildebrand MS; Jackson VE; Scerri TS; Van Reyk O; Coleman M; Braden RO; Turner S; Rigbye KA; Boys A; Barton S; Webster R; Fahey M; Saunders K; Parry-Fielder B; Paxton G; Hayman M; Coman D; Goel H; Baxter A; Ma A; Davis N; Reilly S; Delatycki M; Liégeois FJ; Connelly A; Gecz J; Fisher SE; Amor DJ; Scheffer IE; Bahlo M; Morgan AT
    Neurology; 2020 May; 94(20):e2148-e2167. PubMed ID: 32345733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic aetiologies for childhood speech disorder: novel pathways co-expressed during brain development.
    Kaspi A; Hildebrand MS; Jackson VE; Braden R; van Reyk O; Howell T; Debono S; Lauretta M; Morison L; Coleman MJ; Webster R; Coman D; Goel H; Wallis M; Dabscheck G; Downie L; Baker EK; Parry-Fielder B; Ballard K; Harrold E; Ziegenfusz S; Bennett MF; Robertson E; Wang L; Boys A; Fisher SE; Amor DJ; Scheffer IE; Bahlo M; Morgan AT
    Mol Psychiatry; 2023 Apr; 28(4):1647-1663. PubMed ID: 36117209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language.
    Snijders Blok L; Rousseau J; Twist J; Ehresmann S; Takaku M; Venselaar H; Rodan LH; Nowak CB; Douglas J; Swoboda KJ; Steeves MA; Sahai I; Stumpel CTRM; Stegmann APA; Wheeler P; Willing M; Fiala E; Kochhar A; Gibson WT; Cohen ASA; Agbahovbe R; Innes AM; Au PYB; Rankin J; Anderson IJ; Skinner SA; Louie RJ; Warren HE; Afenjar A; Keren B; Nava C; Buratti J; Isapof A; Rodriguez D; Lewandowski R; Propst J; van Essen T; Choi M; Lee S; Chae JH; Price S; Schnur RE; Douglas G; Wentzensen IM; Zweier C; Reis A; Bialer MG; Moore C; Koopmans M; Brilstra EH; Monroe GR; van Gassen KLI; van Binsbergen E; Newbury-Ecob R; Bownass L; Bader I; Mayr JA; Wortmann SB; Jakielski KJ; Strand EA; Kloth K; Bierhals T; ; Roberts JD; Petrovich RM; Machida S; Kurumizaka H; Lelieveld S; Pfundt R; Jansen S; Deriziotis P; Faivre L; Thevenon J; Assoum M; Shriberg L; Kleefstra T; Brunner HG; Wade PA; Fisher SE; Campeau PM
    Nat Commun; 2018 Nov; 9(1):4619. PubMed ID: 30397230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoallelic expression of the human FOXP2 speech gene.
    Adegbola AA; Cox GF; Bradshaw EM; Hafler DA; Gimelbrant A; Chess A
    Proc Natl Acad Sci U S A; 2015 Jun; 112(22):6848-54. PubMed ID: 25422445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speech and language deficits are central to SETBP1 haploinsufficiency disorder.
    Morgan A; Braden R; Wong MMK; Colin E; Amor D; Liégeois F; Srivastava S; Vogel A; Bizaoui V; Ranguin K; Fisher SE; van Bon BW
    Eur J Hum Genet; 2021 Aug; 29(8):1216-1225. PubMed ID: 33907317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KAT6A mutations in Arboleda-Tham syndrome drive epigenetic regulation of posterior HOXC cluster.
    Singh M; Spendlove SJ; Wei A; Bondhus LM; Nava AA; de L Vitorino FN; Amano S; Lee J; Echeverria G; Gomez D; Garcia BA; Arboleda VA
    Hum Genet; 2023 Dec; 142(12):1705-1720. PubMed ID: 37861717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small intragenic deletion in FOXP2 associated with childhood apraxia of speech and dysarthria.
    Turner SJ; Hildebrand MS; Block S; Damiano J; Fahey M; Reilly S; Bahlo M; Scheffer IE; Morgan AT
    Am J Med Genet A; 2013 Sep; 161A(9):2321-6. PubMed ID: 23918746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and architecture of de novo mutations in developmental disorders.
    Deciphering Developmental Disorders Study
    Nature; 2017 Feb; 542(7642):433-438. PubMed ID: 28135719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic architecture of childhood speech disorder: a review.
    Morgan AT; Amor DJ; St John MD; Scheffer IE; Hildebrand MS
    Mol Psychiatry; 2024 May; 29(5):1281-1292. PubMed ID: 38366112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of deep speech phenotyping for neurodevelopmental and genetic disorders: a conceptual review.
    Chenausky KV; Tager-Flusberg H
    J Neurodev Disord; 2022 Jun; 14(1):36. PubMed ID: 35690736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of candidate-gene CNTNAP2 in childhood apraxia of speech and specific language impairment.
    Centanni TM; Sanmann JN; Green JR; Iuzzini-Seigel J; Bartlett C; Sanger WG; Hogan TP
    Am J Med Genet B Neuropsychiatr Genet; 2015 Oct; 168(7):536-43. PubMed ID: 26097074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dorsal language stream anomalies in an inherited speech disorder.
    Liégeois FJ; Turner SJ; Mayes A; Bonthrone AF; Boys A; Smith L; Parry-Fielder B; Mandelstam S; Spencer-Smith M; Bahlo M; Scerri TS; Hildebrand MS; Scheffer IE; Connelly A; Morgan AT
    Brain; 2019 Apr; 142(4):966-977. PubMed ID: 30796815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding the genetics of speech and language.
    Graham SA; Fisher SE
    Curr Opin Neurobiol; 2013 Feb; 23(1):43-51. PubMed ID: 23228431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum.
    Reuter MS; Riess A; Moog U; Briggs TA; Chandler KE; Rauch A; Stampfer M; Steindl K; Gläser D; Joset P; ; Krumbiegel M; Rabe H; Schulte-Mattler U; Bauer P; Beck-Wödl S; Kohlhase J; Reis A; Zweier C
    J Med Genet; 2017 Jan; 54(1):64-72. PubMed ID: 27572252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a Pathogenic Role of CSMD1 in Childhood Apraxia of Speech.
    Formicola D; Podda I; Pantaleo M; Andreucci E; Lopergolo D; Giglio S; Santorelli FM; Chilosi A
    Neuropediatrics; 2023 Dec; 54(6):407-411. PubMed ID: 37549685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic pathways involved in human speech disorders.
    den Hoed J; Fisher SE
    Curr Opin Genet Dev; 2020 Dec; 65():103-111. PubMed ID: 32622339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foxp1 expression is essential for sex-specific murine neonatal ultrasonic vocalization.
    Fröhlich H; Rafiullah R; Schmitt N; Abele S; Rappold GA
    Hum Mol Genet; 2017 Apr; 26(8):1511-1521. PubMed ID: 28204507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular evolution of FOXP2, a gene involved in speech and language.
    Enard W; Przeworski M; Fisher SE; Lai CS; Wiebe V; Kitano T; Monaco AP; Pääbo S
    Nature; 2002 Aug; 418(6900):869-72. PubMed ID: 12192408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression.
    Rodríguez-Castañeda F; Lemma RB; Cuervo I; Bengtsen M; Moen LM; Ledsaak M; Eskeland R; Gabrielsen OS
    J Biol Chem; 2018 Oct; 293(40):15439-15454. PubMed ID: 30082317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.